Global Extended Release Drug Market Size, Status and Forecast 2020-2026
![](/report_cover/6975/global-extended-release-drug-market-size-status-n-forecast-2020-2026_en.gif)
This report focuses on the global Extended Release Drug status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Extended Release Drug development in North America, Europe and Asia-Pacific.
The key players covered in this study
The key players covered in this study
- Pfizer
- Mallinckrodt
- Teva
- Johnson & Johnson
- Endo Pharmaceuticals
- Purdue Pharma
- Mylan
- Hisamitsu Pharmaceutical
- Sun Pharmaceutical Industries
- Sustained Release Drug
- Controlled Release Drug
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- North America
- Europe
- Asia-Pacific
- To analyze global Extended Release Drug status, future forecast, growth opportunity, key market and key players.
- To present the Extended Release Drug development in North America, Europe and Asia-Pacific.
- To strategically profile the key players and comprehensively analyze their development plan and strategies.
- To define, describe and forecast the market by type, market and key regions.
- History Year: 2015-2019
- Base Year: 2019
- Estimated Year: 2020
- Forecast Year 2020 to 2026
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Extended Release Drug Revenue
1.4 Market Analysis by Type
1.4.1 Global Extended Release Drug Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Sustained Release Drug
1.4.3 Controlled Release Drug
1.5 Market by Application
1.5.1 Global Extended Release Drug Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacy
1.5.3 Retail Pharmacy
1.5.4 Online Pharmacy
1.6 Coronavirus Disease 2019 (Covid-19): Extended Release Drug Industry Impact
1.6.1 How the Covid-19 is Affecting the Extended Release Drug Industry
1.6.1.1 Extended Release Drug Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Extended Release Drug Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Extended Release Drug Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Extended Release Drug Market Perspective (2015-2026)
2.2 Extended Release Drug Growth Trends by Regions
2.2.1 Extended Release Drug Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Extended Release Drug Historic Market Share by Regions (2015-2020)
2.2.3 Extended Release Drug Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Extended Release Drug Market Growth Strategy
2.3.6 Primary Interviews with Key Extended Release Drug Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Extended Release Drug Players by Market Size
3.1.1 Global Top Extended Release Drug Players by Revenue (2015-2020)
3.1.2 Global Extended Release Drug Revenue Market Share by Players (2015-2020)
3.1.3 Global Extended Release Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Extended Release Drug Market Concentration Ratio
3.2.1 Global Extended Release Drug Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Extended Release Drug Revenue in 2019
3.3 Extended Release Drug Key Players Head office and Area Served
3.4 Key Players Extended Release Drug Product Solution and Service
3.5 Date of Enter into Extended Release Drug Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Extended Release Drug Historic Market Size by Type (2015-2020)
4.2 Global Extended Release Drug Forecasted Market Size by Type (2021-2026)
5 EXTENDED RELEASE DRUG BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Extended Release Drug Market Size by Application (2015-2020)
5.2 Global Extended Release Drug Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Extended Release Drug Market Size (2015-2020)
6.2 Extended Release Drug Key Players in North America (2019-2020)
6.3 North America Extended Release Drug Market Size by Type (2015-2020)
6.4 North America Extended Release Drug Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Extended Release Drug Market Size (2015-2020)
7.2 Extended Release Drug Key Players in Europe (2019-2020)
7.3 Europe Extended Release Drug Market Size by Type (2015-2020)
7.4 Europe Extended Release Drug Market Size by Application (2015-2020)
8 ASIA-PACIFIC
8.1 Asia-Pacific Extended Release Drug Market Size (2015-2020)
8.2 Extended Release Drug Key Players in Asia-Pacific (2019-2020)
8.3 Asia-Pacific Extended Release Drug Market Size by Type (2015-2020)
8.4 Asia-Pacific Extended Release Drug Market Size by Application (2015-2020)
(2015-2020)
(2015-2020)
9 KEY PLAYERS PROFILES
9.1 Pfizer
9.1.1 Pfizer Company Details
9.1.2 Pfizer Business Overview and Its Total Revenue
9.1.3 Pfizer Extended Release Drug Introduction
9.1.4 Pfizer Revenue in Extended Release Drug Business (2015-2020))
9.1.5 Pfizer Recent Development
9.2 Mallinckrodt
9.2.1 Mallinckrodt Company Details
9.2.2 Mallinckrodt Business Overview and Its Total Revenue
9.2.3 Mallinckrodt Extended Release Drug Introduction
9.2.4 Mallinckrodt Revenue in Extended Release Drug Business (2015-2020)
9.2.5 Mallinckrodt Recent Development
9.3 Teva
9.3.1 Teva Company Details
9.3.2 Teva Business Overview and Its Total Revenue
9.3.3 Teva Extended Release Drug Introduction
9.3.4 Teva Revenue in Extended Release Drug Business (2015-2020)
9.3.5 Teva Recent Development
9.4 Johnson & Johnson
9.4.1 Johnson & Johnson Company Details
9.4.2 Johnson & Johnson Business Overview and Its Total Revenue
9.4.3 Johnson & Johnson Extended Release Drug Introduction
9.4.4 Johnson & Johnson Revenue in Extended Release Drug Business (2015-2020)
9.4.5 Johnson & Johnson Recent Development
9.5 Endo Pharmaceuticals
9.5.1 Endo Pharmaceuticals Company Details
9.5.2 Endo Pharmaceuticals Business Overview and Its Total Revenue
9.5.3 Endo Pharmaceuticals Extended Release Drug Introduction
9.5.4 Endo Pharmaceuticals Revenue in Extended Release Drug Business (2015-2020)
9.5.5 Endo Pharmaceuticals Recent Development
9.6 Purdue Pharma
9.6.1 Purdue Pharma Company Details
9.6.2 Purdue Pharma Business Overview and Its Total Revenue
9.6.3 Purdue Pharma Extended Release Drug Introduction
9.6.4 Purdue Pharma Revenue in Extended Release Drug Business (2015-2020)
9.6.5 Purdue Pharma Recent Development
9.7 Mylan
9.7.1 Mylan Company Details
9.7.2 Mylan Business Overview and Its Total Revenue
9.7.3 Mylan Extended Release Drug Introduction
9.7.4 Mylan Revenue in Extended Release Drug Business (2015-2020)
9.7.5 Mylan Recent Development
9.8 Hisamitsu Pharmaceutical
9.8.1 Hisamitsu Pharmaceutical Company Details
9.8.2 Hisamitsu Pharmaceutical Business Overview and Its Total Revenue
9.8.3 Hisamitsu Pharmaceutical Extended Release Drug Introduction
9.8.4 Hisamitsu Pharmaceutical Revenue in Extended Release Drug Business (2015-2020)
9.8.5 Hisamitsu Pharmaceutical Recent Development
9.9 Sun Pharmaceutical Industries
9.9.1 Sun Pharmaceutical Industries Company Details
9.9.2 Sun Pharmaceutical Industries Business Overview and Its Total Revenue
9.9.3 Sun Pharmaceutical Industries Extended Release Drug Introduction
9.9.4 Sun Pharmaceutical Industries Revenue in Extended Release Drug Business (2015-2020)
9.9.5 Sun Pharmaceutical Industries Recent Development
10 ANALYST'S VIEWPOINTS/CONCLUSIONS
11 APPENDIX
11.1 Research Methodology
11.1.1 Methodology/Research Approach
11.1.2 Data Source
11.2 Disclaimer
11.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Extended Release Drug Revenue
1.4 Market Analysis by Type
1.4.1 Global Extended Release Drug Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Sustained Release Drug
1.4.3 Controlled Release Drug
1.5 Market by Application
1.5.1 Global Extended Release Drug Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacy
1.5.3 Retail Pharmacy
1.5.4 Online Pharmacy
1.6 Coronavirus Disease 2019 (Covid-19): Extended Release Drug Industry Impact
1.6.1 How the Covid-19 is Affecting the Extended Release Drug Industry
1.6.1.1 Extended Release Drug Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Extended Release Drug Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Extended Release Drug Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Extended Release Drug Market Perspective (2015-2026)
2.2 Extended Release Drug Growth Trends by Regions
2.2.1 Extended Release Drug Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Extended Release Drug Historic Market Share by Regions (2015-2020)
2.2.3 Extended Release Drug Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Extended Release Drug Market Growth Strategy
2.3.6 Primary Interviews with Key Extended Release Drug Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Extended Release Drug Players by Market Size
3.1.1 Global Top Extended Release Drug Players by Revenue (2015-2020)
3.1.2 Global Extended Release Drug Revenue Market Share by Players (2015-2020)
3.1.3 Global Extended Release Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Extended Release Drug Market Concentration Ratio
3.2.1 Global Extended Release Drug Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Extended Release Drug Revenue in 2019
3.3 Extended Release Drug Key Players Head office and Area Served
3.4 Key Players Extended Release Drug Product Solution and Service
3.5 Date of Enter into Extended Release Drug Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Extended Release Drug Historic Market Size by Type (2015-2020)
4.2 Global Extended Release Drug Forecasted Market Size by Type (2021-2026)
5 EXTENDED RELEASE DRUG BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Extended Release Drug Market Size by Application (2015-2020)
5.2 Global Extended Release Drug Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Extended Release Drug Market Size (2015-2020)
6.2 Extended Release Drug Key Players in North America (2019-2020)
6.3 North America Extended Release Drug Market Size by Type (2015-2020)
6.4 North America Extended Release Drug Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Extended Release Drug Market Size (2015-2020)
7.2 Extended Release Drug Key Players in Europe (2019-2020)
7.3 Europe Extended Release Drug Market Size by Type (2015-2020)
7.4 Europe Extended Release Drug Market Size by Application (2015-2020)
8 ASIA-PACIFIC
8.1 Asia-Pacific Extended Release Drug Market Size (2015-2020)
8.2 Extended Release Drug Key Players in Asia-Pacific (2019-2020)
8.3 Asia-Pacific Extended Release Drug Market Size by Type (2015-2020)
8.4 Asia-Pacific Extended Release Drug Market Size by Application (2015-2020)
(2015-2020)
(2015-2020)
9 KEY PLAYERS PROFILES
9.1 Pfizer
9.1.1 Pfizer Company Details
9.1.2 Pfizer Business Overview and Its Total Revenue
9.1.3 Pfizer Extended Release Drug Introduction
9.1.4 Pfizer Revenue in Extended Release Drug Business (2015-2020))
9.1.5 Pfizer Recent Development
9.2 Mallinckrodt
9.2.1 Mallinckrodt Company Details
9.2.2 Mallinckrodt Business Overview and Its Total Revenue
9.2.3 Mallinckrodt Extended Release Drug Introduction
9.2.4 Mallinckrodt Revenue in Extended Release Drug Business (2015-2020)
9.2.5 Mallinckrodt Recent Development
9.3 Teva
9.3.1 Teva Company Details
9.3.2 Teva Business Overview and Its Total Revenue
9.3.3 Teva Extended Release Drug Introduction
9.3.4 Teva Revenue in Extended Release Drug Business (2015-2020)
9.3.5 Teva Recent Development
9.4 Johnson & Johnson
9.4.1 Johnson & Johnson Company Details
9.4.2 Johnson & Johnson Business Overview and Its Total Revenue
9.4.3 Johnson & Johnson Extended Release Drug Introduction
9.4.4 Johnson & Johnson Revenue in Extended Release Drug Business (2015-2020)
9.4.5 Johnson & Johnson Recent Development
9.5 Endo Pharmaceuticals
9.5.1 Endo Pharmaceuticals Company Details
9.5.2 Endo Pharmaceuticals Business Overview and Its Total Revenue
9.5.3 Endo Pharmaceuticals Extended Release Drug Introduction
9.5.4 Endo Pharmaceuticals Revenue in Extended Release Drug Business (2015-2020)
9.5.5 Endo Pharmaceuticals Recent Development
9.6 Purdue Pharma
9.6.1 Purdue Pharma Company Details
9.6.2 Purdue Pharma Business Overview and Its Total Revenue
9.6.3 Purdue Pharma Extended Release Drug Introduction
9.6.4 Purdue Pharma Revenue in Extended Release Drug Business (2015-2020)
9.6.5 Purdue Pharma Recent Development
9.7 Mylan
9.7.1 Mylan Company Details
9.7.2 Mylan Business Overview and Its Total Revenue
9.7.3 Mylan Extended Release Drug Introduction
9.7.4 Mylan Revenue in Extended Release Drug Business (2015-2020)
9.7.5 Mylan Recent Development
9.8 Hisamitsu Pharmaceutical
9.8.1 Hisamitsu Pharmaceutical Company Details
9.8.2 Hisamitsu Pharmaceutical Business Overview and Its Total Revenue
9.8.3 Hisamitsu Pharmaceutical Extended Release Drug Introduction
9.8.4 Hisamitsu Pharmaceutical Revenue in Extended Release Drug Business (2015-2020)
9.8.5 Hisamitsu Pharmaceutical Recent Development
9.9 Sun Pharmaceutical Industries
9.9.1 Sun Pharmaceutical Industries Company Details
9.9.2 Sun Pharmaceutical Industries Business Overview and Its Total Revenue
9.9.3 Sun Pharmaceutical Industries Extended Release Drug Introduction
9.9.4 Sun Pharmaceutical Industries Revenue in Extended Release Drug Business (2015-2020)
9.9.5 Sun Pharmaceutical Industries Recent Development
10 ANALYST'S VIEWPOINTS/CONCLUSIONS
11 APPENDIX
11.1 Research Methodology
11.1.1 Methodology/Research Approach
11.1.2 Data Source
11.2 Disclaimer
11.3 Author Details
LIST OF TABLES
Table 1. Extended Release Drug Key Market Segments
Table 2. Key Players Covered: Ranking by Extended Release Drug Revenue
Table 3. Ranking of Global Top Extended Release Drug Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Extended Release Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Sustained Release Drug
Table 6. Key Players of Controlled Release Drug
Table 7. COVID-19 Impact Global Market: (Four Extended Release Drug Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Extended Release Drug Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Extended Release Drug Players to Combat Covid-19 Impact
Table 12. Global Extended Release Drug Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Extended Release Drug Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Extended Release Drug Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Extended Release Drug Market Share by Regions (2015-2020)
Table 16. Global Extended Release Drug Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Extended Release Drug Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Extended Release Drug Market Growth Strategy
Table 22. Main Points Interviewed from Key Extended Release Drug Players
Table 23. Global Extended Release Drug Revenue by Players (2015-2020) (Million US$)
Table 24. Global Extended Release Drug Market Share by Players (2015-2020)
Table 25. Global Top Extended Release Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Extended Release Drug as of 2019)
Table 26. Global Extended Release Drug by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Extended Release Drug Product Solution and Service
Table 29. Date of Enter into Extended Release Drug Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Extended Release Drug Market Size by Type (2015-2020) (Million US$)
Table 32. Global Extended Release Drug Market Size Share by Type (2015-2020)
Table 33. Global Extended Release Drug Revenue Market Share by Type (2021-2026)
Table 34. Global Extended Release Drug Market Size Share by Application (2015-2020)
Table 35. Global Extended Release Drug Market Size by Application (2015-2020) (Million US$)
Table 36. Global Extended Release Drug Market Size Share by Application (2021-2026)
Table 37. North America Key Players Extended Release Drug Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Extended Release Drug Market Share (2019-2020)
Table 39. North America Extended Release Drug Market Size by Type (2015-2020) (Million US$)
Table 40. North America Extended Release Drug Market Share by Type (2015-2020)
Table 41. North America Extended Release Drug Market Size by Application (2015-2020) (Million US$)
Table 42. North America Extended Release Drug Market Share by Application (2015-2020)
Table 43. Europe Key Players Extended Release Drug Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Extended Release Drug Market Share (2019-2020)
Table 45. Europe Extended Release Drug Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Extended Release Drug Market Share by Type (2015-2020)
Table 47. Europe Extended Release Drug Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Extended Release Drug Market Share by Application (2015-2020)
Table 49. Asia-Pacific Key Players Extended Release Drug Revenue (2019-2020) (Million US$)
Table 50. Asia-Pacific Key Players Extended Release Drug Market Share (2019-2020)
Table 51. Asia-Pacific Extended Release Drug Market Size by Type (2015-2020) (Million US$)
Table 52. Asia-Pacific Extended Release Drug Market Share by Type (2015-2020)
Table 53. Asia-Pacific Extended Release Drug Market Size by Application (2015-2020) (Million US$)
Table 54. Asia-Pacific Extended Release Drug Market Share by Application (2015-2020)
Table 55. Pfizer Company Details
Table 56. Pfizer Business Overview
Table 57. Pfizer Product
Table 58. Pfizer Revenue in Extended Release Drug Business (2015-2020) (Million US$)
Table 59. Pfizer Recent Development
Table 60. Mallinckrodt Company Details
Table 61. Mallinckrodt Business Overview
Table 62. Mallinckrodt Product
Table 63. Mallinckrodt Revenue in Extended Release Drug Business (2015-2020) (Million US$)
Table 64. Mallinckrodt Recent Development
Table 65. Teva Company Details
Table 66. Teva Business Overview
Table 67. Teva Product
Table 68. Teva Revenue in Extended Release Drug Business (2015-2020) (Million US$)
Table 69. Teva Recent Development
Table 70. Johnson & Johnson Company Details
Table 71. Johnson & Johnson Business Overview
Table 72. Johnson & Johnson Product
Table 73. Johnson & Johnson Revenue in Extended Release Drug Business (2015-2020) (Million US$)
Table 74. Johnson & Johnson Recent Development
Table 75. Endo Pharmaceuticals Company Details
Table 76. Endo Pharmaceuticals Business Overview
Table 77. Endo Pharmaceuticals Product
Table 78. Endo Pharmaceuticals Revenue in Extended Release Drug Business (2015-2020) (Million US$)
Table 79. Endo Pharmaceuticals Recent Development
Table 80. Purdue Pharma Company Details
Table 81. Purdue Pharma Business Overview
Table 82. Purdue Pharma Product
Table 83. Purdue Pharma Revenue in Extended Release Drug Business (2015-2020) (Million US$)
Table 84. Purdue Pharma Recent Development
Table 85. Mylan Company Details
Table 86. Mylan Business Overview
Table 87. Mylan Product
Table 88. Mylan Revenue in Extended Release Drug Business (2015-2020) (Million US$)
Table 89. Mylan Recent Development
Table 90. Hisamitsu Pharmaceutical Business Overview
Table 91. Hisamitsu Pharmaceutical Product
Table 92. Hisamitsu Pharmaceutical Company Details
Table 93. Hisamitsu Pharmaceutical Revenue in Extended Release Drug Business (2015-2020) (Million US$)
Table 94. Hisamitsu Pharmaceutical Recent Development
Table 95. Sun Pharmaceutical Industries Company Details
Table 96. Sun Pharmaceutical Industries Business Overview
Table 97. Sun Pharmaceutical Industries Product
Table 98. Sun Pharmaceutical Industries Revenue in Extended Release Drug Business (2015-2020) (Million US$)
Table 99. Sun Pharmaceutical Industries Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
Table 1. Extended Release Drug Key Market Segments
Table 2. Key Players Covered: Ranking by Extended Release Drug Revenue
Table 3. Ranking of Global Top Extended Release Drug Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Extended Release Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Sustained Release Drug
Table 6. Key Players of Controlled Release Drug
Table 7. COVID-19 Impact Global Market: (Four Extended Release Drug Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Extended Release Drug Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Extended Release Drug Players to Combat Covid-19 Impact
Table 12. Global Extended Release Drug Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Extended Release Drug Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Extended Release Drug Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Extended Release Drug Market Share by Regions (2015-2020)
Table 16. Global Extended Release Drug Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Extended Release Drug Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Extended Release Drug Market Growth Strategy
Table 22. Main Points Interviewed from Key Extended Release Drug Players
Table 23. Global Extended Release Drug Revenue by Players (2015-2020) (Million US$)
Table 24. Global Extended Release Drug Market Share by Players (2015-2020)
Table 25. Global Top Extended Release Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Extended Release Drug as of 2019)
Table 26. Global Extended Release Drug by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Extended Release Drug Product Solution and Service
Table 29. Date of Enter into Extended Release Drug Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Extended Release Drug Market Size by Type (2015-2020) (Million US$)
Table 32. Global Extended Release Drug Market Size Share by Type (2015-2020)
Table 33. Global Extended Release Drug Revenue Market Share by Type (2021-2026)
Table 34. Global Extended Release Drug Market Size Share by Application (2015-2020)
Table 35. Global Extended Release Drug Market Size by Application (2015-2020) (Million US$)
Table 36. Global Extended Release Drug Market Size Share by Application (2021-2026)
Table 37. North America Key Players Extended Release Drug Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Extended Release Drug Market Share (2019-2020)
Table 39. North America Extended Release Drug Market Size by Type (2015-2020) (Million US$)
Table 40. North America Extended Release Drug Market Share by Type (2015-2020)
Table 41. North America Extended Release Drug Market Size by Application (2015-2020) (Million US$)
Table 42. North America Extended Release Drug Market Share by Application (2015-2020)
Table 43. Europe Key Players Extended Release Drug Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Extended Release Drug Market Share (2019-2020)
Table 45. Europe Extended Release Drug Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Extended Release Drug Market Share by Type (2015-2020)
Table 47. Europe Extended Release Drug Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Extended Release Drug Market Share by Application (2015-2020)
Table 49. Asia-Pacific Key Players Extended Release Drug Revenue (2019-2020) (Million US$)
Table 50. Asia-Pacific Key Players Extended Release Drug Market Share (2019-2020)
Table 51. Asia-Pacific Extended Release Drug Market Size by Type (2015-2020) (Million US$)
Table 52. Asia-Pacific Extended Release Drug Market Share by Type (2015-2020)
Table 53. Asia-Pacific Extended Release Drug Market Size by Application (2015-2020) (Million US$)
Table 54. Asia-Pacific Extended Release Drug Market Share by Application (2015-2020)
Table 55. Pfizer Company Details
Table 56. Pfizer Business Overview
Table 57. Pfizer Product
Table 58. Pfizer Revenue in Extended Release Drug Business (2015-2020) (Million US$)
Table 59. Pfizer Recent Development
Table 60. Mallinckrodt Company Details
Table 61. Mallinckrodt Business Overview
Table 62. Mallinckrodt Product
Table 63. Mallinckrodt Revenue in Extended Release Drug Business (2015-2020) (Million US$)
Table 64. Mallinckrodt Recent Development
Table 65. Teva Company Details
Table 66. Teva Business Overview
Table 67. Teva Product
Table 68. Teva Revenue in Extended Release Drug Business (2015-2020) (Million US$)
Table 69. Teva Recent Development
Table 70. Johnson & Johnson Company Details
Table 71. Johnson & Johnson Business Overview
Table 72. Johnson & Johnson Product
Table 73. Johnson & Johnson Revenue in Extended Release Drug Business (2015-2020) (Million US$)
Table 74. Johnson & Johnson Recent Development
Table 75. Endo Pharmaceuticals Company Details
Table 76. Endo Pharmaceuticals Business Overview
Table 77. Endo Pharmaceuticals Product
Table 78. Endo Pharmaceuticals Revenue in Extended Release Drug Business (2015-2020) (Million US$)
Table 79. Endo Pharmaceuticals Recent Development
Table 80. Purdue Pharma Company Details
Table 81. Purdue Pharma Business Overview
Table 82. Purdue Pharma Product
Table 83. Purdue Pharma Revenue in Extended Release Drug Business (2015-2020) (Million US$)
Table 84. Purdue Pharma Recent Development
Table 85. Mylan Company Details
Table 86. Mylan Business Overview
Table 87. Mylan Product
Table 88. Mylan Revenue in Extended Release Drug Business (2015-2020) (Million US$)
Table 89. Mylan Recent Development
Table 90. Hisamitsu Pharmaceutical Business Overview
Table 91. Hisamitsu Pharmaceutical Product
Table 92. Hisamitsu Pharmaceutical Company Details
Table 93. Hisamitsu Pharmaceutical Revenue in Extended Release Drug Business (2015-2020) (Million US$)
Table 94. Hisamitsu Pharmaceutical Recent Development
Table 95. Sun Pharmaceutical Industries Company Details
Table 96. Sun Pharmaceutical Industries Business Overview
Table 97. Sun Pharmaceutical Industries Product
Table 98. Sun Pharmaceutical Industries Revenue in Extended Release Drug Business (2015-2020) (Million US$)
Table 99. Sun Pharmaceutical Industries Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Extended Release Drug Market Share by Type: 2020 VS 2026
Figure 2. Sustained Release Drug Features
Figure 3. Controlled Release Drug Features
Figure 4. Global Extended Release Drug Market Share by Application: 2020 VS 2026
Figure 5. Hospital Pharmacy Case Studies
Figure 6. Retail Pharmacy Case Studies
Figure 7. Online Pharmacy Case Studies
Figure 8. Extended Release Drug Report Years Considered
Figure 9. Global Extended Release Drug Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Extended Release Drug Market Share by Regions: 2020 VS 2026
Figure 11. Global Extended Release Drug Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Extended Release Drug Market Share by Players in 2019
Figure 14. Global Top Extended Release Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Extended Release Drug as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Extended Release Drug Revenue in 2019
Figure 16. North America Extended Release Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Extended Release Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Asia-Pacific Extended Release Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 20. Pfizer Revenue Growth Rate in Extended Release Drug Business (2015-2020)
Figure 21. Mallinckrodt Total Revenue (US$ Million): 2019 Compared with 2018
Figure 22. Mallinckrodt Revenue Growth Rate in Extended Release Drug Business (2015-2020)
Figure 23. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Teva Revenue Growth Rate in Extended Release Drug Business (2015-2020)
Figure 25. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Johnson & Johnson Revenue Growth Rate in Extended Release Drug Business (2015-2020)
Figure 27. Endo Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Endo Pharmaceuticals Revenue Growth Rate in Extended Release Drug Business (2015-2020)
Figure 29. Purdue Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Purdue Pharma Revenue Growth Rate in Extended Release Drug Business (2015-2020)
Figure 31. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Mylan Revenue Growth Rate in Extended Release Drug Business (2015-2020)
Figure 33. Hisamitsu Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Hisamitsu Pharmaceutical Revenue Growth Rate in Extended Release Drug Business (2015-2020)
Figure 35. Sun Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Sun Pharmaceutical Industries Revenue Growth Rate in Extended Release Drug Business (2015-2020)
Figure 37. Bottom-up and Top-down Approaches for This Report
Figure 38. Data Triangulation
Figure 39. Key Executives Interviewed
Figure 1. Global Extended Release Drug Market Share by Type: 2020 VS 2026
Figure 2. Sustained Release Drug Features
Figure 3. Controlled Release Drug Features
Figure 4. Global Extended Release Drug Market Share by Application: 2020 VS 2026
Figure 5. Hospital Pharmacy Case Studies
Figure 6. Retail Pharmacy Case Studies
Figure 7. Online Pharmacy Case Studies
Figure 8. Extended Release Drug Report Years Considered
Figure 9. Global Extended Release Drug Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Extended Release Drug Market Share by Regions: 2020 VS 2026
Figure 11. Global Extended Release Drug Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Extended Release Drug Market Share by Players in 2019
Figure 14. Global Top Extended Release Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Extended Release Drug as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Extended Release Drug Revenue in 2019
Figure 16. North America Extended Release Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Extended Release Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Asia-Pacific Extended Release Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 20. Pfizer Revenue Growth Rate in Extended Release Drug Business (2015-2020)
Figure 21. Mallinckrodt Total Revenue (US$ Million): 2019 Compared with 2018
Figure 22. Mallinckrodt Revenue Growth Rate in Extended Release Drug Business (2015-2020)
Figure 23. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Teva Revenue Growth Rate in Extended Release Drug Business (2015-2020)
Figure 25. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Johnson & Johnson Revenue Growth Rate in Extended Release Drug Business (2015-2020)
Figure 27. Endo Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Endo Pharmaceuticals Revenue Growth Rate in Extended Release Drug Business (2015-2020)
Figure 29. Purdue Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Purdue Pharma Revenue Growth Rate in Extended Release Drug Business (2015-2020)
Figure 31. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Mylan Revenue Growth Rate in Extended Release Drug Business (2015-2020)
Figure 33. Hisamitsu Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Hisamitsu Pharmaceutical Revenue Growth Rate in Extended Release Drug Business (2015-2020)
Figure 35. Sun Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Sun Pharmaceutical Industries Revenue Growth Rate in Extended Release Drug Business (2015-2020)
Figure 37. Bottom-up and Top-down Approaches for This Report
Figure 38. Data Triangulation
Figure 39. Key Executives Interviewed